Ivacaftor: (Moderate) Increased monitoring is recommended if ivacaftor is administered concurrently with CYP2C9 substrates, such as sildenafil.
Sildenafil citrate is manufactured by several pharmaceutical companies.
Its chemical formula is C22H30N6O4S.
It has a half-life of approximately 4 hours in the body.
The drug enhances nitric oxide activity in the corpus cavernosum.
It’s important to follow prescribed dosing to avoid adverse effects.
It is classified as a phosphodiesterase type 5 inhibitor.
Sildenafil was initially researched for angina before ED use.
Ivosidenib: (Moderate) Monitor for loss of efficacy of sildenafil during coadministration of ivosidenib; a sildenafil dose adjustment may be necessary.
Advice To Patients
Indinavir: (Major) Sildenafil is contraindicated for use with indinavir when used for pulmonary arterial hypertension (PAH). In a small pharmacokinetic study, the coadministration of a single dose of sildenafil (25 mg) to patients receiving indinavir (800 mg every 8 hours) resulted in markedly increased sildenafil AUC values (340% increase), as compared to historical controls. In two of the six subjects, prolonged clinical effects of sildenafil were noted for 72 hours after a single dose of sildenafil. Isavuconazonium: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with isavuconazonium is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction. Isocarboxazid: (Moderate) Additive hypotensive effects may be seen when monoamine oxidase inhibitors (MAOIs) are combined with sildenafil.
Platelet-aggregation Inhibitors
Careful monitoring of blood pressure is suggested during concurrent therapy of MAOIs with sildenafil. It can be expected that concomitant administration of CYP3A4 enzyme-inducers, such as rifampin, will decrease plasma levels of sildenafil, however, no interaction studies have been performed. Isoniazid, INH; Rifampin: (Minor) Sildenafil is metabolized principally by cytochrome P450 3A4 and 2C9 enzymes. Itraconazole: (Major) Avoid use of sildenafil for the treatment of pulmonary hypertension during and for 2 weeks after discontinuation of itraconazole treatment. When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving itraconazole. Sildenafil is a sensitive substrate of CYP3A4; ivosidenib induces CYP3A4 and may lead to decreased sildenafil concentrations. Ketoconazole: (Major) Coadministration of ketoconazole is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving ketoconazole.
Product
Dosage
Quantity + Bonus
Price
Viagra Generic
150mg
10 Pills
36.73€ 34.98€
Viagra Generic
25mg
60 + 4 Pills
71.99€ 68.56€
Viagra Generic
150mg
360 + 10 Pills
423.48€ 403.31€
Kamagra Polo
100mg
272 + 12 Pills
622.94€ 593.28€
Viagra Generic
200mg
10 Pills
40.96€ 39.01€
Viagra Generic
25mg
10 Pills
25.19€ 23.99€
Kamagra
100mg
84 + 6 Pills
264.44€ 251.85€
Viagra Generic
100mg
120 + 6 Pills
149.50€ 142.38€
Kamagra
100mg
20 Pills
86.09€ 81.99€
Viagra Generic
25mg
30 + 4 Pills
47.97€ 45.69€
Kamagra Polo
100mg
180 + 8 Pills
446.52€ 425.26€
Kamagra Soft Tabs
100mg
120 + 6 Pills
311.78€ 296.93€
Viagra Generic
25mg
360 + 10 Pills
213.68€ 203.50€
Viagra Generic
25mg
20 Pills
37.74€ 35.94€
Viagra Generic
25mg
270 + 8 Pills
184.26€ 175.49€
Lansoprazole; Amoxicillin; Clarithromycin: (Major) Coadministration of clarithromycin is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH).
Property
Description
Value
Units
Molecular Weight
The mass of one mole of sildenafil citrate
474.58
g/mol
Chemical Formula
Molecular composition
C22H30N6O4S
Solubility
Water solubility
Slightly soluble
at 25°C
pH of Solution
Typical pH when dissolved in water
3.8 - 4.2
Melting Point
The temperature at which it melts
196 - 198
°C
Lefamulin: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with oral lefamulin is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction.
Dosing & Uses
Sildenafil levels may increase; it is possible that sildenafil-induced side effects could also be increased in some individuals. One study has confirmed a potential interaction; sildenafil's AUC increased 23 percent with coadministration of grapefruit juice. Guaifenesin; Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors. Hydantoins: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with phenytoin is necessary as concurrent use may decrease sildenafil exposure. Sildenafil is a sensitive CYP3A substrate and phenytoin is a strong CYP3A inducer.
Can I take Viagra by snorting it?
Consistent with their known effects on the nitric oxide/cGMP pathway, concomitant use of phosphodiesterase inhibitors and nitrates can cause severe hypotension, syncope, or myocardial infarction. Deaths have been reported in men who were using sildenafil while taking nitrate or nitrite therapy for angina. Idelalisib: (Major) Coadministration of idelalisib is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving idelalisib. Imatinib: (Moderate) Monitor for an increase in sildenafil-related adverse reactions sildenafil 50g if coadministration with imatinib is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction. Sildenafil is a sensitive CYP3A4 substrate and oral lefamulin is a moderate CYP3A4 inhibitor; an interaction is not expected with intravenous lefamulin.
Sildenafil shortens the time to achieve an erection.
It does not cause spontaneous erections without sexual stimulation.
Overdose signs include vision changes, persistent erections, or hypotension.
It is linked to priapism, a sustained and painful erection.
Always consult a healthcare provider before starting sildenafil.
Store medication in a cool, dry place away from children.
Combining with recreational drugs can cause dangerous interactions.
Lenacapavir: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with lenacapavir is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. Sildenafil is a sensitive CYP3A substrate and lenacapavir is a moderate CYP3A inhibitor. In a drug interaction study, coadministration with a moderate CYP3A inhibitor increased the AUC of sildenafil by 182%.
Adult Indications and Dosage
Monitor the therapeutic effect of sildenafil during coadministration with fenofibric acid. Fluconazole: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with fluconazole is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. Fluvoxamine: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with fluvoxamine is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction. In a drug interaction study, coadministration of fluvoxamine increased the sildenafil AUC by 40%. Fosamprenavir: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with fosamprenavir is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction.
Common Adverse Effects
When used for pulmonary arterial hypertension, this combination is listed as a contraindication in the fosamprenavir FDA-approved labeling. In a drug interaction study, coadministration with a moderate CYP3A inhibitor increased the Cmax and AUC of sildenafil by 160% and 182%, respectively. Glycerol Phenylbutyrate: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with glycerol phenylbutyrate is necessary as concurrent use may decrease sildenafil exposure. Grapefruit juice: (Moderate) Sildenafil is metabolized via the cytochrome CYP 3A4 isozyme. Grapefruit juice contains a compound that inhibits CYP3A4 in enterocytes in the GI tract. Lesinurad: (Moderate) Lesinurad may decrease the systemic exposure and therapeutic efficacy of sildenafil; monitor for potential reduction in efficacy. Lesinurad; Allopurinol: (Moderate) Lesinurad may decrease the systemic exposure and therapeutic efficacy of sildenafil; monitor for potential reduction in efficacy. Letermovir: (Major) Monitor for an increase in sildenafil-related adverse reactions if coadministration with letermovir is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction.
Sildenafil is available in most countries through prescription only.
It is used worldwide, with varying approval statuses.
FDA and EMA have rigorous testing standards for sildenafil.
Using the drug responsibly can lead to successful treatment outcomes.
Combining sildenafil with other medications requires medical supervision.
Be aware of the potential for drug interactions with heart or blood pressure meds.
Always consult a healthcare professional for personalized advice.
Concurrent use is not recommended in patients receiving sildenafil for pulmonary arterial hypertension and taking cyclosporine, because the magnitude of the interaction may be amplified.
What other drugs will affect sildenafil?
Concurrent use may decrease sildenafil plasma concentrations. Population pharmacokinetic analysis of data from patients in clinical trials indicated approximately 3-fold the sildenafil clearance when it was coadministered with weak CYP3A inducers. Elagolix; Estradiol; Norethindrone acetate: (Moderate) Monitor for reduced therapeutic effect of sildenafil if coadministered with elagolix. Elbasvir; Grazoprevir: (Moderate) Administering sildenafil with elbasvir; grazoprevir may result in elevated sildenafil plasma concentrations. If these drugs are used together, closely monitor for signs of adverse events.
Sildenafil vs. tadalafil
Elexacaftor; tezacaftor; ivacaftor: (Moderate) Increased monitoring is recommended if ivacaftor is administered concurrently with CYP2C9 substrates, such as sildenafil. Ivacaftor is an inhibitor of CYP3A and a weak inhibitor of CYP2C9; sildenafil is metabolized by CYP3A and CYP2C9. Co-administration of ivacaftor with CYP3A and CYP2C9 substrates, such as sildenafil, can theoretically increase sildenafil exposure leading to increased or prolonged therapeutic effects and adverse events; however, the clinical impact of this has not yet been determined. Encorafenib: (Moderate) Coadministration of encorafenib with sildenafil may result in increased toxicity or decreased efficacy of sildenafil. In vitro studies with encorafenib showed time-dependent inhibition of CYP3A4 and induction of CYP3A4. Consider a starting dose of 25 mg of sildenafil for erectile dysfunction in patients receiving letermovir with cyclosporine.
Brand Name
Manufacturer
Formulation Type
Typical Dosage
Notes
Viagra
Pfizer
Tablet
25, 50, 100 mg
Most well-known brand
Revatio
Pfizer
Tablet
20 mg
For pulmonary hypertension
Sildenafil Citrate
Various generic manufacturers
Tablet
25, 50, 100 mg
Generic versions available
Kamagra
Ajanta Pharma
Oral Gel
100 mg
Used off-label in some countries
Letermovir is a moderate CYP3A4 inhibitor; however, when given with cyclosporine, the combined effect on CYP3A4 substrates is similar to a strong CYP3A4 inhibitor.
At a glance
The clinical relevance of the in vivo effect of encorafenib on CYP3A4 is not established. Enzalutamide: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with enzalutamide is necessary. Erythromycin: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with erythromycin is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. In a drug interaction study, coadministration with erythromycin increased the Cmax and AUC of sildenafil by 160% and 182%, respectively. Etravirine: (Moderate) Etravirine is an inducer of CYP3A4; coadministration may result in decreased sildenafil concentrations.
Taking Viagra with food
Dosage adjustments may be needed based on clinical efficacy. Fedratinib: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with fedratinib is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. Fenofibric Acid: (Minor) At therapeutic concentrations, fenofibric acid is a mild-to-moderate inhibitor of CYP2C9. Concomitant use tablet sildenafil 50 mg of fenofibric acid with CYP2C9 substrates, such as sildenafil , has not been formally studied. Fenofibric acid may theoretically increase plasma concentrations of CYP2C9 substrates and could lead to toxicity for drugs that have a narrow therapeutic range.